MEVAC Launches Major Facility Expansion with EGP 5 Billion Investment to Strengthen Global Leadership in Veterinary Health
Egypt
MEVAC celebrated the grand opening of a major expansion of its facilities—an important strategic milestone in the company’s journey toward global leadership in veterinary health.
This expansion aims to triple the production capacity of veterinary vaccines, backed by an investment of EGP 5 billion. The project includes a state-of-the-art inactivated vaccine production center and a modern research and development center, further solidifying MEVAC’s role as a key provider of veterinary vaccines in over 42 countries, with plans to expand exports to more than 90 countries by 2030.
The inauguration ceremony was attended by MEVAC’s Board of Directors along with a number of prominent political figures, highlighting the company’s steadfast commitment to saving lives and advancing health through innovative vaccines and solutions.
This achievement was made possible through the efforts of an exceptional team of executive leaders and experts, led by:
- Dr. Magdy El Sayed – Chairman of the Board
- Dr. Ahmed El Kady – Chief Executive Officer
